Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.9%

50 terminated/withdrawn out of 458 trials

Success Rate

84.0%

-2.5% vs industry average

Late-Stage Pipeline

26%

119 trials in Phase 3/4

Results Transparency

42%

109 of 262 completed trials have results

Key Signals

47 recruiting109 with results31 terminated19 withdrawn

Enrollment Performance

Analytics

N/A
154(41.7%)
Phase 4
71(19.2%)
Phase 2
61(16.5%)
Phase 3
48(13.0%)
Phase 1
27(7.3%)
Early Phase 1
8(2.2%)
369Total
N/A(154)
Phase 4(71)
Phase 2(61)
Phase 3(48)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (458)

Showing 20 of 458 trials
NCT03122197Early Phase 1Recruiting

Study of Letrozole in Recurrent Gliomas

Role: lead

NCT07213934Phase 1Recruiting

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Role: lead

NCT05911568Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

Role: lead

NCT05047172Phase 3Active Not Recruiting

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Role: collaborator

NCT06059664Phase 2Recruiting

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Role: collaborator

NCT07528638Not ApplicableNot Yet Recruiting

Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)

Role: lead

NCT06919653Not ApplicableNot Yet Recruiting

Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses

Role: lead

NCT06130501Not ApplicableActive Not Recruiting

tAN for PTSD and OUD in Buprenorphine Therapy

Role: lead

NCT05948566Phase 2Recruiting

Strategy for Improving Stroke Treatment Response

Role: collaborator

NCT07494890Not ApplicableRecruiting

Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment

Role: lead

NCT06163482Early Phase 1Recruiting

Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis

Role: lead

NCT07468695Not ApplicableNot Yet Recruiting

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

Role: collaborator

NCT07464886Phase 3Recruiting

Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth

Role: lead

NCT06545760Not ApplicableRecruiting

Admission to Kangaroo Mother Care (KMC) Ward and Maternal Postpartum Depression

Role: collaborator

NCT07447895Not ApplicableNot Yet Recruiting

Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

Role: lead

NCT07115056Phase 4Withdrawn

Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction

Role: collaborator

NCT05304078Not ApplicableActive Not Recruiting

Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III)

Role: lead

NCT05316584Not ApplicableActive Not Recruiting

A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy

Role: collaborator

NCT05706311Not ApplicableActive Not Recruiting

Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool

Role: collaborator

NCT06470295Early Phase 1Recruiting

Effect of C-peptide on Hypoglycemic Counterregulation

Role: lead